AIDS Vaccine Science for Busy Advocates – Passive Immunization: An important piece of the puzzle

A one-page document describing passive immunization, the transfer of pre-made antibodies, and its potential for HIV prevention.

HIV Vaccines: Key messages

This is a three-page document providing main points surrounding vaccine research. For a shorter one-page version of this, click here.

Pre-Exposure Prophylaxis: An introductory factsheet

This introductory 2-page document defines PrEP, reviews the scientific evidence to date, and outlines key research, regulatory and advocacy issues going forward. This factsheet is part of a series on emerging HIV prevention strategies.

Treatment as Prevention: An introductory factsheet

This introductory 2-page document defines treatment as prevention, reviews the scientific evidence behind it, and outlines implementation advocacy priorities. The factsheet is part of a series on emerging HIV prevention strategies.

Microbicides for HIV Prevention: An introductory factsheet

This introductory 2-page document defines microbicides and reviews the state of research on some leading candidates.

Multipurpose Prevention Technologies (MPTs): An introductory factsheet

This introductory 2-page document makes the case for why women need prevention options that protect them against multiple risks—HIV, STIs and/or pregnancy—and discusses the products that are being studied for this purpose. The factsheet is part of a series on emerging HIV prevention strategies.

Press Statement from Kenya AIDS Civil Society AIDS Groups Cheer First Major New Commitment by Presidential Candidate

This press release from a coalition of Kenyan civil society groups celebrates a success in an election-year campaign led by 2013 AVAC Advocacy Fellow Maureen Milanga to secure commitments to good HIV policy by political candidates. The pledge by Prime Minister Raila Odinga committed his administration, if elected, to provide universal access to antiretroviral therapy and to spend 15 percent of the national budget on healthcare.

Online CHAIN MSM Survey: Willingness and influencing factors for usage of PrEP among MSM

This study of 760 men who have sex with men in China, conducted by 2013 AVAC Advocacy Fellow Cai Lingping, finds high acceptability of pre-exposure prophylaxis. The survey also assessed how well informed respondents were about PrEP and examined factors that would make them more or less willing to take it.

HIV Civil Society Recommendations for Kenya’s New Health Secretary and Global Fund Application

This letter, written by a civil society coalition co-led by 2013 AVAC Advocacy Fellow Maureen Milanga, summarizes concerns and demands related to Kenya’s 2013 application to the Global Fund. The letter was sent during the Global Fund’s transition to its New Funding Model and includes guidance to the Government of Kenya on how to navigate the new system to secure support for ambitious treatment scale-up in the wake of new WHO treatment guidelines.

The Change We Need to End AIDS in Uganda: A civil society analysis of the state of Uganda’s AIDS response

This document, developed by a coalition of civil society groups co-led by AVAC Advocacy Fellows Alice Kayong-Mutebi, Richard Hasunira and Sylvia Nakasi, identifies failures in the Ugandan AIDS response and a 10-point plan to end the country’s epidemic.